AI Science Tracker

Machine learning guided XylM variant improved biosensor-indicated productivity

The University of Tokyo; National Institute of Advanced Industrial Science and Technology; AIST-Waseda University Computational Bio Big-Data Open Innovation Laboratory · 3 Feb 2023 · biology

Discovery

Machine learning guided XylM variant improved biosensor-indicated productivity

Two machine-learning-assisted directed-evolution cycles produced XylM-D140E-V144K-F243L-N244S, reported to have 15-fold higher 3-methylsalicylic acid productivity than wild-type XylM. Productivity was estimated using XylS-dependent fluorescence in a sensor strain; this is a biosensor-based productivity readout, not a purified-enzyme kinetic constant.

Technology: Machine-learning-assisted directed evolution using biosensor-derived activity data

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The publisher reports XylM-D140E-V144K-F243L-N244S with 15-fold greater 3-methylsalicylic-acid productivity than wild type after two ML-assisted directed-evolution cycles, using XylS-dependent fluorescence from a sensor strain as the measured indicator.
  • Still unknown: The signal is an indirect biosensor-based productivity proxy; the reported value is not a purified-enzyme kinetic constant.
  • AI role: Machine learning used sensor-derived data to guide two rounds of directed evolution and prioritize XylM variants.

Evidence sources: https://pubs.acs.org/doi/abs/10.1021/acssynbio.2c00577 · https://pubmed.ncbi.nlm.nih.gov/36734676/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary ACS publisher indexed abstract and affiliation/article-history metadata, cross-checked against primary PubMed abstract and metadata..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.